Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2

Long COVID is a well-known complication to COVID-19 that affect millions of people worldwide and causes wide range of symptoms. We present a rare case of a previously diagnosed follicular lymphoma patient, who had a long COVID with persistent negative SARS-CoV-2 antibodies and required an aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Tayar, Elias, Isber, Ryan, Isber, Nidal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284434/
https://www.ncbi.nlm.nih.gov/pubmed/37378376
http://dx.doi.org/10.1016/j.heliyon.2023.e17149
_version_ 1785061401475153920
author Tayar, Elias
Isber, Ryan
Isber, Nidal
author_facet Tayar, Elias
Isber, Ryan
Isber, Nidal
author_sort Tayar, Elias
collection PubMed
description Long COVID is a well-known complication to COVID-19 that affect millions of people worldwide and causes wide range of symptoms. We present a rare case of a previously diagnosed follicular lymphoma patient, who had a long COVID with persistent negative SARS-CoV-2 antibodies and required an aggressive antiviral treatment.
format Online
Article
Text
id pubmed-10284434
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102844342023-06-22 Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2 Tayar, Elias Isber, Ryan Isber, Nidal Heliyon Case Report Long COVID is a well-known complication to COVID-19 that affect millions of people worldwide and causes wide range of symptoms. We present a rare case of a previously diagnosed follicular lymphoma patient, who had a long COVID with persistent negative SARS-CoV-2 antibodies and required an aggressive antiviral treatment. Elsevier 2023-06-21 /pmc/articles/PMC10284434/ /pubmed/37378376 http://dx.doi.org/10.1016/j.heliyon.2023.e17149 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Tayar, Elias
Isber, Ryan
Isber, Nidal
Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_full Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_fullStr Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_full_unstemmed Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_short Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_sort long covid treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to sars-cov2
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284434/
https://www.ncbi.nlm.nih.gov/pubmed/37378376
http://dx.doi.org/10.1016/j.heliyon.2023.e17149
work_keys_str_mv AT tayarelias longcovidtreatedsuccessfullywithantiviralsinarituximabtreatedfollicularlymphomapatientwithpersistentnegativeantibodiestosarscov2
AT isberryan longcovidtreatedsuccessfullywithantiviralsinarituximabtreatedfollicularlymphomapatientwithpersistentnegativeantibodiestosarscov2
AT isbernidal longcovidtreatedsuccessfullywithantiviralsinarituximabtreatedfollicularlymphomapatientwithpersistentnegativeantibodiestosarscov2

Ejemplares similares